Recombinant Human GDF7 Protein，His

GDF7, or Growth/Differentiation Factor 7, is a member of the transforming growth factor-beta (TGF-β) superfamily, primarily known for its roles in bone and cartilage development. Research on GDF7 has gained significant attention due to its potential therapeutic applications in regenerative medicine, particularly in tissue engineering and repair. It plays a crucial role in the differentiation of mesenchymal stem cells and has been shown to promote chondrogenesis, making it a valuable target for treating osteoarthritis and cartilage injuries. Additionally, GDF7 influences the development of sensory neurons, suggesting its involvement in pain modulation and neuroprotection. Consequently, the recombinant production of GDF7 is vital for conducting in vitro studies to explore its biological functions and therapeutic efficacy. Various expression systems, including bacterial, yeast, and mammalian cells, have been employed to produce functional GDF7 protein. Due to its complex post-translational modifications, particularly glycosylation, mammalian systems are preferred for optimal yields of bioactive GDF7. This research area focuses on understanding the signaling pathways mediated by GDF7 and its interactions with other growth factors, which could unlock new strategies for treating musculoskeletal disorders and enhancing tissue regeneration. Furthermore, the investigation into its mechanisms of action may lead to novel insights into pain management and peripheral nerve regeneration. As scientists continue to elucidate the multifaceted roles of GDF7, the recombinant protein will serve as an essential tool in preclinical and clinical studies aimed at leveraging its biological properties for therapeutic benefit.